{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T03:30:53Z","timestamp":1775791853360,"version":"3.50.1"},"reference-count":22,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2020,9,29]]},"DOI":"10.1536\/ihj.20-256","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T22:05:07Z","timestamp":1599861907000},"page":"944-950","source":"Crossref","is-referenced-by-count":11,"title":["Comparison of Landiolol and Digoxin as an Intravenous Drug for Controlling the Heart Rate in Patients with Atrial Fibrillation and Severely Depressed Left Ventricular Function"],"prefix":"10.1536","volume":"61","author":[{"given":"Masaya","family":"Shinohara","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryou","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Yano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Akitsu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Koike","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeya","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Fujino","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003; 91: 2D-8D.","DOI":"10.1016\/S0002-9149(02)03373-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bui AL, Grau-Sepulveda MV, Hernandez AF, <i>et al<\/i>. Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation. Am Heart J 2013; 165: 567-74.","DOI":"10.1016\/j.ahj.2013.01.007"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 1997; 30: 1039-45.","DOI":"10.1016\/S0735-1097(97)00254-4"},{"key":"4","unstructured":"4. Rawles JM. What is meant by a &quot;controlled&quot; ventricular rate in atrial fibrillation? Br Heart J 1990; 63: 157-61."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hasenfuss G, Holubarsch C, Hermann HP, Astheimer K, Pleske B, Just H. Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. Eur Heart J 1994; 15: 164-70.","DOI":"10.1093\/oxfordjournals.eurheartj.a060471"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hess PL, Sheng S, Matsouaka R, <i>et al<\/i>. Strict versus lenient versus poor rate control among patients with atrial fibrillation and heart failure (from the get with the guidelines - heart failure program). Am J Cardiol 2020; 125: 894-900.","DOI":"10.1016\/j.amjcard.2019.12.025"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Takahama H, Yokoyama H, Kada A, <i>et al<\/i>. The extent of heart rate reduction during hospitalization using beta-blockers, not the achieved heart rate itself at discharge, predicts the clinical outcome in patients with acute heart failure syndromes. J Cardiol 2013; 61: 58-64.","DOI":"10.1016\/j.jjcc.2012.08.014"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group. Intravenous digoxin in acute atrial fibrillation: Results of a randomized, placebo-controlled multicentre trial in 239 patients: The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group. Eur Heart J 1997; 18: 649-54.","DOI":"10.1093\/oxfordjournals.eurheartj.a015311"},{"key":"9","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1161\/01.CIR.0000132482.95686.87","volume":"109","year":"2004","unstructured":"9. Gheorghiade M, Adams Jr KF, Colucci WS. Digoxin in the management of cardiovascular disorders. Circulation 2004; 109: 2959-64.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kobayashi S, Susa T, Tanaka T, <i>et al<\/i>. Low-dose \u03b2-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure. Circ J 2012; 76: 1646-53.","DOI":"10.1253\/circj.CJ-12-0033"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nitta D, Kinugawa K, Imamura T, <i>et al<\/i>. An experience of landiolol use for an advanced heart failure patient with severe hypotension. Int Heart J 2015; 56: 564-7.","DOI":"10.1536\/ihj.15-103"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yamashita T, Nakasu Y, Mizutani H, Sumitani K. A prospective observational survey on landiolol in atrial fibrillation\/atrial flutter patients with chronic heart failure-AF-CHF landiolol survey. J Cardiol 2019; 74: 418-25.","DOI":"10.1016\/j.jjcc.2019.05.012"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nagai R, Kinugawa K, Inoue H, <i>et al<\/i>. Urgent management of rapid heart rate in patients with atrial fibrillation\/flutter and left ventricular dysfunction: comparison of the ultrashort-acting beta1-selective blocker landiolol with digoxin (J-Land Study). Circ J 2013; 77: 908-16.","DOI":"10.1253\/circj.CJ-12-1618"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Van Gelder IC, Groenveld HF, Crijns HJ, <i>et al<\/i>. RACE II Investigators. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 2010; 362: 1363-73.","DOI":"10.1056\/NEJMoa1001337"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Santhanakrishnan R, Wang N, Larson MG, <i>et al<\/i>. Atrial fibrillation begets heart failure and vice versa: Temporal associations and differences in preserved versus reduced ejection fraction. Circulation 2016; 133: 484-92.","DOI":"10.1161\/CIRCULATIONAHA.115.018614"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Wada Y, Aiba T, Tsujita Y, <i>et al<\/i>. Practical applicability of landiolol, an ultra-short-acting \u03b21-selective blocker, for rapid atrial and ventricular tachyarrhythmias with left ventricular dysfunction. J Arrhythm 2016; 32: 82-8.","DOI":"10.1016\/j.joa.2015.09.002"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ponikowski P, Voors AA, Anker SD, <i>et al<\/i>. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129-200.","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"18","first-page":"e137","volume":"136","year":"2017","unstructured":"18. Yancy CW, Jessup M, Bozkurt B, <i>et al<\/i>. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the heart failure society of America. Circulation 2017; 136: e137-61.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Farshi R, Kistner D, Sarma JS, Longmate JA, Singh BN. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. J Am Coll Cardiol 1999; 33: 304-10.","DOI":"10.1016\/S0735-1097(98)00561-0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Eichhorn EJ, Gheorghiade M. Digoxin. Prog Cardiovasc Dis 2002; 44: 251-66.","DOI":"10.1053\/pcad.2002.31591"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Sae-Lim O, Doungngern T, Jaisue S, <i>et al<\/i>. Prediction of serum digoxin concentration using estimated glomerular filtration rate in Thai population. Int J Gen Med 2019; 12: 455-63.","DOI":"10.2147\/IJGM.S218393"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Tuegel C, Bansal N. Heart failure in patients with kidney disease. Heart 2017; 103: 1848-53.","DOI":"10.1136\/heartjnl-2016-310794"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/5\/61_20-256\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T03:56:54Z","timestamp":1601697414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/5\/61_20-256\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-256","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]}}}